Matches in Wikidata for { <http://www.wikidata.org/entity/Q37026726> ?p ?o ?g. }
- Q37026726 description "article científic" @default.
- Q37026726 description "article scientifique" @default.
- Q37026726 description "articolo scientifico" @default.
- Q37026726 description "artigo científico" @default.
- Q37026726 description "artículu científicu espublizáu en 2013" @default.
- Q37026726 description "bilimsel makale" @default.
- Q37026726 description "scientific article published on 09 April 2013" @default.
- Q37026726 description "vedecký článok" @default.
- Q37026726 description "vetenskaplig artikel" @default.
- Q37026726 description "videnskabelig artikel" @default.
- Q37026726 description "vědecký článek" @default.
- Q37026726 description "wetenschappelijk artikel" @default.
- Q37026726 description "wissenschaftlicher Artikel" @default.
- Q37026726 description "наукова стаття, опублікована у квітні 2013" @default.
- Q37026726 description "научни чланак" @default.
- Q37026726 description "مقالة علمية نشرت في 09 أبريل 2013" @default.
- Q37026726 name "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 name "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 name "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 type Item @default.
- Q37026726 label "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 label "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 label "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 prefLabel "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 prefLabel "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 prefLabel "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 P1104 Q37026726-C0A62037-4881-4FC1-9053-F5E8A2DF18CB @default.
- Q37026726 P1433 Q37026726-B103A505-79D2-4AB8-82CF-E532942C170A @default.
- Q37026726 P1476 Q37026726-C08A760A-D0A0-4990-A729-F903CD9A0463 @default.
- Q37026726 P2093 Q37026726-29ADBC8A-FC40-4751-A63C-EC467397F9E8 @default.
- Q37026726 P2093 Q37026726-2BFE5312-6B2F-490B-A2C1-FB8A4A9061B5 @default.
- Q37026726 P2093 Q37026726-5535108A-8855-4C89-9F4B-E3E1EA2795A3 @default.
- Q37026726 P2093 Q37026726-708CEEDE-ED53-4C7B-A297-40BDA06675B9 @default.
- Q37026726 P2093 Q37026726-8236AAB2-9994-4D00-9D6C-BA8826A5DF0F @default.
- Q37026726 P2093 Q37026726-9D877555-3D48-47D1-97DC-C941AD98AE4A @default.
- Q37026726 P2093 Q37026726-9FFBF4E0-E005-4DB9-A069-9AE57A832A1C @default.
- Q37026726 P2093 Q37026726-A6C2D146-AA12-4516-B288-7F77C9AB2B94 @default.
- Q37026726 P2093 Q37026726-B37A4287-55C3-4B71-9130-3B827568981A @default.
- Q37026726 P2093 Q37026726-E5F0F814-68AC-4EC0-B183-F6EC4AA159B6 @default.
- Q37026726 P2860 Q37026726-00C23527-7765-48BE-9313-03371FCDF46B @default.
- Q37026726 P2860 Q37026726-10367C2C-3959-4306-A014-E878A314421F @default.
- Q37026726 P2860 Q37026726-206F3799-62F5-49DD-8FAE-4E5BD68BE67D @default.
- Q37026726 P2860 Q37026726-27ABF6CB-75FD-4115-BD01-5357D5918178 @default.
- Q37026726 P2860 Q37026726-2F49AD2A-825C-49AD-9A6D-8C092A6A3980 @default.
- Q37026726 P2860 Q37026726-41321036-5E03-4592-BE2C-DF87D7DB24E2 @default.
- Q37026726 P2860 Q37026726-420E68B7-70EE-4610-BBB7-66F02F060650 @default.
- Q37026726 P2860 Q37026726-44CD0B89-E093-4D6F-B820-CFB73051422C @default.
- Q37026726 P2860 Q37026726-4AFDFE23-1A5F-43A1-ADAD-2FCAF950256B @default.
- Q37026726 P2860 Q37026726-4DF43EDB-D74E-4B15-A916-77192711CF07 @default.
- Q37026726 P2860 Q37026726-576FD1BD-D2C3-4EA7-9A9E-0EC81B15F9E6 @default.
- Q37026726 P2860 Q37026726-63C40779-9226-4044-8B22-13E1D31CF353 @default.
- Q37026726 P2860 Q37026726-8986B82F-FE76-4CDC-9FA5-7288BA513AAD @default.
- Q37026726 P2860 Q37026726-A5EF02FA-5760-4D21-A0D0-D520FB898643 @default.
- Q37026726 P2860 Q37026726-A96CCDF8-1F19-4002-958E-25EA4A3F434E @default.
- Q37026726 P2860 Q37026726-C2FED3E8-C4F0-40AB-B2DC-213BD98CAF2D @default.
- Q37026726 P2860 Q37026726-C3252B10-E961-4353-80D1-98E42646C606 @default.
- Q37026726 P2860 Q37026726-C33C09DF-92A3-4CB5-9F0E-09309B175A8D @default.
- Q37026726 P2860 Q37026726-C49480F8-F65D-4883-92AD-C8926BF76469 @default.
- Q37026726 P2860 Q37026726-CDF91D23-72B7-464F-9175-0F578B8B809D @default.
- Q37026726 P2860 Q37026726-CFF8B993-DE35-4526-909C-EC27C31555E9 @default.
- Q37026726 P2860 Q37026726-D42D31E8-09D5-4C42-8B4C-DB459FE77196 @default.
- Q37026726 P2860 Q37026726-E7BBD16F-F6CB-4C59-951F-4D1F4802574C @default.
- Q37026726 P2860 Q37026726-EF21629D-58E3-4D31-B4C3-8A02213A947F @default.
- Q37026726 P2860 Q37026726-F838DFC5-2682-42CD-AF98-4A1FB9C7E923 @default.
- Q37026726 P2860 Q37026726-FE15B2C5-6F65-40B3-A703-AFB15992077A @default.
- Q37026726 P304 Q37026726-153E46CE-BC31-4FFC-99F2-5BC6906BEA7D @default.
- Q37026726 P31 Q37026726-819EBB02-A676-4CBD-9009-0F6F8BDBA3A1 @default.
- Q37026726 P356 Q37026726-32C95716-158A-483F-B456-239D90F97FA7 @default.
- Q37026726 P407 Q37026726-BAA16896-ECF2-4911-8C16-7931B74070DF @default.
- Q37026726 P433 Q37026726-57EA4392-5658-4256-AA3F-0A2EE2C20166 @default.
- Q37026726 P478 Q37026726-840FB2F3-2F4A-49E0-9DD8-E77719B3B914 @default.
- Q37026726 P50 Q37026726-14858E40-6BF7-4E06-B85F-EEB1F0C3D03B @default.
- Q37026726 P50 Q37026726-65B6E0B1-4E7A-4BE6-AF36-508F228C9426 @default.
- Q37026726 P577 Q37026726-4CFD5A16-FAD4-423D-B6A3-30A3CBE851BA @default.
- Q37026726 P5875 Q37026726-45E62333-FCE3-4109-91F7-14516A3CB3BE @default.
- Q37026726 P698 Q37026726-242B2CD5-6D73-4655-956C-3DC763CD5205 @default.
- Q37026726 P921 Q37026726-47A33354-E97D-4B06-A5EB-A97B1848F877 @default.
- Q37026726 P921 Q37026726-4E6FA48B-2276-4233-9EA5-4F8D6AA9D21C @default.
- Q37026726 P921 Q37026726-928E8454-97B1-4A69-A08A-23F1330C3193 @default.
- Q37026726 P921 Q37026726-C052E545-5A9C-4EE9-B1ED-14E58417FB6F @default.
- Q37026726 P932 Q37026726-14F45CAE-8E94-4A85-B16D-12A5E31EE926 @default.
- Q37026726 P356 AAC.00216-13 @default.
- Q37026726 P698 23571544 @default.
- Q37026726 P1104 "+8" @default.
- Q37026726 P1433 Q578004 @default.
- Q37026726 P1476 "Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints" @default.
- Q37026726 P2093 "Ajay Sudan" @default.
- Q37026726 P2093 "Andrew Sharp" @default.
- Q37026726 P2093 "Joanne Goodwin" @default.
- Q37026726 P2093 "Joanne Livermore" @default.
- Q37026726 P2093 "Lea Gregson" @default.
- Q37026726 P2093 "Peter A Warn" @default.
- Q37026726 P2093 "Susan J Howard" @default.
- Q37026726 P2093 "Thomas S Harrison" @default.
- Q37026726 P2093 "Tim W Felton" @default.
- Q37026726 P2093 "Zaid Al-Nakeeb" @default.
- Q37026726 P2860 Q27315103 @default.
- Q37026726 P2860 Q29617372 @default.
- Q37026726 P2860 Q33588561 @default.
- Q37026726 P2860 Q33938166 @default.